Ignite Creation Date:
2024-07-17 @ 10:54 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500689
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
To Assess Allisartan IsoproxilSustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
Sponsor:
Shenzhen Salubris Pharmaceuticals Co Ltd
Organization:
Shenzhen Salubris Pharmaceuticals Co Ltd